These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 22737371)

  • 21. Intravitreal Bevacizumab for Management of Choroidal Osteoma without Choroidal Neovascularization.
    Najafabadi FF; Hendimarjan SM; Zarrin Y; Najafabadi MF
    J Ophthalmic Vis Res; 2015; 10(4):484-6. PubMed ID: 27051495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravitreal bevacizumab for treatment of choroidal neovascularization secondary to toxoplasmic retinochoroiditis: a case series.
    Kianersi F; Naderi Beni A; Naderi Beni Z; Ghanbari H
    Semin Ophthalmol; 2015 May; 30(3):181-7. PubMed ID: 24175641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced-fluence photodynamic therapy combined with intravitreal bevacizumab for polypoidal choroidal vasculopathy.
    Sagong M; Lim S; Chang W
    Am J Ophthalmol; 2012 May; 153(5):873-882.e2. PubMed ID: 22265146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MICROSTRUCTURAL EFFECTS OF INTRAVITREAL BEVACIZUMAB IN IDIOPATHIC CHOROIDAL NEOVASCULARISATION.
    Shah SN; Kang QY; Fan XJ; Shahbaz F
    J Ayub Med Coll Abbottabad; 2015; 27(2):259-63. PubMed ID: 26411092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture.
    Barth T; Zeman F; Helbig H; Gamulescu MA
    BMC Ophthalmol; 2019 Nov; 19(1):239. PubMed ID: 31771544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complete regression of choroidal metastasis secondary to non-small-cell lung cancer with intravitreal bevacizumab and oral erlotinib combination therapy.
    Kim SW; Kim MJ; Huh K; Oh J
    Ophthalmologica; 2009; 223(6):411-3. PubMed ID: 19628953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unrelenting Ocular Pain as a Masquerading Symptom of Occult Choroidal Metastasis.
    Deaner JD; Pointdujour-Lim R; Say EA; Shields CL
    Ocul Oncol Pathol; 2017 Jan; 3(1):56-59. PubMed ID: 28275605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Macular functional changes evaluated with MP-1 microperimetry after intravitreal bevacizumab for subfoveal myopic choroidal neovascularization: one-year results.
    Scupola A; Tiberti AC; Sasso P; Savastano MC; Mastrocola A; Marangoni D; Minnella AM; Falsini B; Balestrazzi E
    Retina; 2010 May; 30(5):739-47. PubMed ID: 20038860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced depth imaging optical coherence tomography of the choroid in central retinal vein occlusion.
    Tsuiki E; Suzuma K; Ueki R; Maekawa Y; Kitaoka T
    Am J Ophthalmol; 2013 Sep; 156(3):543-547.e1. PubMed ID: 23688711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bevacizumab for treatment of choroidal neovascularization secondary to candida chorioretinitis.
    Makragiannis G; Vahdani K; Carreño E; Lee RWJ; Dick AD; Ross AH
    Int Ophthalmol; 2018 Apr; 38(2):781-785. PubMed ID: 28361379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravitreal bevacizumab for exudative branching vascular networks in polypoidal choroidal vasculopathy.
    Wakabayashi T; Gomi F; Sawa M; Tsujikawa M; Nishida K
    Br J Ophthalmol; 2012 Mar; 96(3):394-9. PubMed ID: 21719568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravitreal bevacizumab for choroidal neovascularization secondary to presumed ocular histoplasmosis syndrome.
    Ehrlich R; Ciulla TA; Maturi R; Kheradiya NS; Hrisomalos N; Shulman S; Guess MG; Coyle E; Harris A
    Retina; 2009; 29(10):1418-23. PubMed ID: 19898179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of Choroidal Neovascular Membranes Associated with Choroidal Nevi.
    Munie MT; Demirci H
    Ophthalmol Retina; 2018 Jan; 2(1):53-58. PubMed ID: 31047303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Intravitreal bevacizumab for choroidal neovascularization associated with Best's disease].
    Velazquez-Villoria D; Macià Badia C; Rigo Quera J; Velez-Escola L; Arcos-Algaba G; Martínez-Castillo V; García-Arumí J
    Arch Soc Esp Oftalmol; 2014 Oct; 89(10):405-7. PubMed ID: 24508228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Case Report of Intravitreal Bevacizumab for Iris Metastasis of Small Cell Lung Carcinoma with Neovascular Glaucoma.
    Hidaka T; Chuman H; Nao-I N
    Case Rep Ophthalmol; 2018; 9(2):401-404. PubMed ID: 30283326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Choroidal metastasis as a presenting manifestation of lung cancer: a report of 3 cases and systematic review of the literature.
    Singh N; Kulkarni P; Aggarwal AN; Mittal BR; Gupta N; Behera D; Gupta A
    Medicine (Baltimore); 2012 Jul; 91(4):179-194. PubMed ID: 22732948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravitreal bevacizumab as a primary treatment for idiopathic choroidal neovascularization.
    Cheema RA; Mushtaq J; Cheema MA
    Middle East Afr J Ophthalmol; 2011 Jul; 18(3):220-3. PubMed ID: 21887077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks: A report of two patients.
    Ozkaya A; Alkin Z; Faiz M; Yazici AT; Demirok A
    Saudi J Ophthalmol; 2014 Oct; 28(4):316-8. PubMed ID: 25473350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiographic results of retinal-retinal anastomosis and retinal-choroidal anastomosis after treatments in eyes with retinal angiomatous proliferation.
    Saito M; Iida T; Kano M; Itagaki K
    Clin Ophthalmol; 2012; 6():1385-91. PubMed ID: 22969283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravitreal bevacizumab for choroidal neovascularization associated with choroidal nevus.
    Chiang A; Bianciotto C; Maguire JI; Park CH; Baker PS; Shields JA; Shields CL
    Retina; 2012 Jan; 32(1):60-7. PubMed ID: 21886019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.